Effect of inhalational anesthesia on cerebral circulation in Moyamoya disease

Journal of Neurosurgical Anesthesiology

Volumn 11, Issue 1, 1999, Pages 25-30

  Sato, Kiyotaka ^a   Shirane, Reizo ^b   Kato, Masato ^b   Yoshimoto, Takashi ^b  

^a KOHNAN HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Inhalation anesthesia; Intracerebral steal; Moyamoya disease; Propofol; Revascularization; Total intravenous anesthesia

Indexed keywords

ANESTHETIC AGENT; DIAZEPAM; FENTANYL; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; PHENYLEPHRINE; PROPOFOL; SEVOFLURANE; VECURONIUM;

ADOLESCENT; ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CEREBROVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFRARED SPECTROSCOPY; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOYAMOYA DISEASE; ORAL DRUG ADMINISTRATION; OXIMETRY; OXYGEN SATURATION; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 0032960784     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-199901000-00005     Document Type: Article

References (31)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease, disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299.
2. Goto Y, Yonekawa Y. Worldwide distribution of Moyamoya disease. Neurol Med Chir 1992;32:883-886.
3. Kikuchi H. Moyamoya disease. Jpn J Stroke 1994;16:393-397.
4. Sato K, Shirane R, Kato M, et al. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Child's Nervous Sys 1997;13:68-72.
5. Yamagishi N, Hashizume K, Matsuzawa N, et al. Anesthetic management of revascularization for moyamoya disease. Masui 1991;40:1132-1137.
6. Yasuda C, Sumida T, Izima M, et al. Anesthetic experience of a child with moyamoya disease. Masui 1989;38:809-812.
7. Kurehara K, Ohnishi H, Touho H, et al. Cortical blood flow response to hypercapnia during anaesthesia in moyamoya disease. Can J Anaesth 1993;40:709-713.
8. Yamada K, Miyamoto S, Nagata I, et al. Reverse steal phenomenon in moyamoya disease. Jpn J Neurosurg 1995;4:145-150.
9. Matta BF, Mayberg TS, Lam AM. Direct cerebrovasodilatory effects of halothane, isoflurane, and desflurane during propofol-induced isoelectric electroencephalogram in humans. Anesthesiology 1995;83:980-985.
10. Scheller MS, Tateishi A, Drummond JC, et al. The effects of sevoflurane on cerebral blood flow, cerebral metabolic rate for oxygen, intracranial pressure, and the electroencephalogram are similar to those of isoflurane in the rabbit. Anesthesiology 1988;68:548-551.
11. Field LM, Dorrance DE, Krzeminska EK, et al. Effect of nitrous oxide on cerebral blood flow in normal humans. Br J Anaesth 1993;70:154-159.
12. Strebel S, Kaufmann M, Anselmi L, et al. Nitrous oxide is a potent cerebrovasodilator in humans when added to isoflurane. Acta Anaesthesiol Scand 1995;39:653-658.
13. Astrup J, Rosenorn J, Cold GE, et al. Minimum cerebral blood flow and metabolism during craniotomy effect of thiopental loading. Acta Anaesthesiol Scand 1984;28:478-181.
14. Stephan H, Sonntag H, Schenk HD, et al. Effects of Disoprivan on cerebral blood flow, cerebral oxygen consumption, and cerebral vascular reactivity. Anaesthesist 1987;36:60-65.
15. Vandesteene A, Trempont V, Engelman E, et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988;43(Suppl):42-43.
16. Kusaka Y, Shirane R, Yoshimoto T. Non-anastomotic bypass surgery for childhood moyamoya disease using dural pedicle insertion over the brain surface combined with EGMS. Surg Neurol (in press).
17. Shirane R, Kusaka Y, Takahashi T, et al. Assessment of encephalo-galeo-myo-synangiosis with dural insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neurosurg 1997;2:579-585.
18. Goetting MG, Preston G. Jugular bulb catheterization: experience with 123 patients. Crit Care Med 1990;18:1220-1223.
19. McCormick PW, Stewart M, Goetting MG, et al. Noninvasive cerebral optical spectroscopy for monitoring cerebral oxygen delivery and hemodynamics. Crit Care Med 1991;19:89-97.
20. Kashima S. Non-contact laser tissue blood flow measurement using polarization to reduce the specular reflection artefact. Optics & Laser Technology 1994;26:169-175.
21. Doze VA, Shafer A, White PF. Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia. Anesthesiology 1988;69:63-71.
22. Morio M, Numata K, Ikeda K, et al. A dose confirming study (induction and maintenance) of propofol, an intravenous anesthetic. Anesth Resus 1993;29:45-56.
23. Madsen JB, Cold GE, Hansen ES, et al. The effect of isoflurane on cerebral blood flow and metabolism in humans during craniotomy for small supratentorial cerebral tumors. Anesthesiology 1987;66:332-336.
24. Algotsson L, Messeter K, Nordstrm CH, et al. Cerebral blood flow and oxygen consumption during isoflurane and halothane anesthesia in man. Acta Anesthesiol Scand 1988;32:15-20.
25. Gepts E, Camu F, Cockshott ID, et al. Disposition of propofol administered as constant rate intravenous infusion in humans. Anesth Analg 1987;66:1256-1263.
26. 2 management. Anesthesiology 1988;69:547-551.
27. Smith AL, Wollman H. Cerebral blood flow and metabolism: Effects of anesthetic drugs and techniques. Anesthesiology 1972;36:378-100.
28. 133Xenon for measurement of regional cerebral blood flow (rCBF) during halothane, enflurane, and isoflurane anesthesia in humans. Anesthesiology 1985;63:391-394.
29. Farling PA, Johnston JR, Coppel DL. Propofol infusion for sedation of patients with head injury in intensive care. Anaesthesia 1989;44:222-226.
30. Mangez JF, Menguy E, Roux P. Constant rate propofol sedation in the head injured patient preliminary data. Ann Fr Anesth Reanim 1987;6:336-337.
31. Alkire MT, Haier RJ, Barker SJ, et al. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology 1995;82:393-403.